Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit
Summary
Johnson & Johnson will pay about $5.5 billion to settle nearly all lawsuits claiming its talc products caused ovarian cancer. The deal covers around 76,000 claims and aims to end a legal fight lasting over ten years, but it still needs approval from most claimants before it is final.Key Facts
- Johnson & Johnson agreed to pay $5.5 billion to resolve talc-related ovarian cancer lawsuits.
- The settlement includes about 76,000 claims in federal and state courts.
- The company denies that its talc products caused cancer and says the claims lack merit.
- Johnson & Johnson will pay $3 billion in 2027 and more payments in 2028, with total costs possibly exceeding $7 billion.
- The deal applies only to existing claims and does not cover future lawsuits.
- The company stopped selling talc-based baby powder in the US in 2020 and now sells a cornstarch-based product.
- Past court battles included some wins and losses for Johnson & Johnson.
- The settlement requires approval from 95% of current claimants to become final.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
